Proactis (PHD) Share Price, News & Analysis

Company Overview

Proactis Holdings PLC, together with its subsidiaries, develops and sells business software, and provides related support services in the United Kingdom, Mainland Europe, the United States, and internationally. The company's solutions cover spend, sourcing, contract, procurement, supplier, project, vendor, budget, expenses, and catalog management; spend intelligence, ERP integration, workforce, payment, accounts payable automation, and spend intelligence and reporting; and integrated digital marketing, selling, and invoicing solutions. It also provides managed sourcing, catalog management, invoice capture, and other related services; and a business framework for buyer/seller interaction and commerce. The company serves the public, education, retail, financial services, not-for-profit, housing authority, property and facilities management, professional services, construction, manufacturing, pharmaceuticals and healthcare, and other sectors. Proactis Holdings PLC was founded in 1996 and is based in Wetherby, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 74 to 74
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 235,848 shs
• Market Capitalization: £70.69 million
• P/E Ratio: N/A
• Dividend Yield: 3.13%
• Price Target: N/A
• Consensus Rating: N/A

PHD Stock Analysis - Frequently Asked Questions

How do I buy shares of Proactis?

Shares of PHD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Proactis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Proactis investors own include Ferrexpo (FXPO), Bushveld Minerals (BMN), Advanced Oncotherapy (AVO), Amryt Pharma (AMYT), Rolls-Royce Holdings plc (RR.L), Staffline Group (STAF) and Whitbread (WTB).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Computer and Technology
• Industry: Business Software & Services
• Sub-Industry: Financial Services
• Current Symbol: LON:PHD
• CUSIP: N/A
• CIK: N/A
• Web: www.proactis.com
• Phone: +44-1937-545070
• Fax: N/A
• Employees: 516
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 107.77
• Current Ratio: 0.67
• Quick Ratio: 0.33

Sales & Book Value

• Annual Sales: £48.90 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 25.52
• Book Value: GBX 50.10 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 95,533,000
• Free Float: N/A
• Market Cap: £70.69 million
• Optionable: Not Optionable
• Beta: N/A